Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Specific binding of (/sup 3/H) dihydrokadsurenone to rabbit platelet membranes and its inhibition by platelet activating factor (PAF) and PAF receptor antagonists

Conference · · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)
OSTI ID:6992481

Kadsurenone inhibits specifically and competitively the specific binding of (/sup 3/H) PAF to rabbit platelet membranes with a K/sub B/ of 9 x 10/sup -8/M. 5-propyl analog of kadsurenone (dihydrokadsurenone) retains roughly the same potency as kadsurenone. To confirm that the inhibitory effect on the specific (/sup 3/H) PAF binding by kadsurenone, dihydrokadsurenone or other PAF receptor antagonists is due to the blockage of the receptor site, (/sup 3/H) dihydrokadsurenone was synthesized. A saturable specific (/sup 3/H) dihydrokadsurenone binding was found with an equilibrium dissociation constant (K/sub D/) of 16.48 (+/- 0.03) nM. The total number of detectable binding sites is 2.32 (+/- 0.09) pmol/mg protein, which is exactly identical to the B/sub max/ of the PAF receptor sites (2.30 +/- (0.40) pmol/mg protein) under identical assay conditions. Both C/sub 16/ and C/sub 18/-PAF fully displaced the specific (/sup 3/H) dihydrokadsurenone (5 nM) binding with an identical ED/sub 50/ of 10/sup -9/M. Dihydrokadsurenone and kadsurenone also displaced the specific binding with roughly the same potency (ED/sub 50/ = 3.6 x 10/sup -8/M). L-652,731 is more potent with an ED/sub 50/ of 2 x 10/sup -8/ M. Ono-6240 and CV-3988 also displaced the binding with ED/sub 50/ of 10/sup -7/ and 4 x 10/sup -7/ M respectively. These results strongly suggest that PAF and these PAF receptor antagonists interact with a common binding site in the PAF receptor.

Research Organization:
Merck Sharp and Dohme Research Labs., Rahway, NJ
OSTI ID:
6992481
Report Number(s):
CONF-8606151-
Journal Information:
Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States), Journal Name: Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) Vol. 45:6; ISSN FEPRA
Country of Publication:
United States
Language:
English